OrbiMed’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,042,000
| Closed | -$15.1K | – | 122 |
|
|
2022
Q3 | $15.1K | Buy |
1,042,000
+856,600
| +462% | +$12.4K | 0.28% | 74 |
|
|
2022
Q2 | $1.82K | Buy |
+185,400
| New | +$1.82K | 0.03% | 128 |
|
|
2020
Q2 | – | Sell |
-420,641
| Closed | -$3.22M | – | 141 |
|
|
2020
Q1 | $3.22M | Buy |
420,641
+260,100
| +162% | +$1.99M | 0.05% | 113 |
|
|
2019
Q4 | $2.86M | Buy |
160,541
+121,808
| +314% | +$2.17M | 0.04% | 111 |
|
|
2019
Q3 | $449K | Buy |
+38,733
| New | +$449K | 0.01% | 106 |
|
|
2019
Q2 | – | Sell |
-90,500
| Closed | -$2.59M | – | 125 |
|
|
2019
Q1 | $2.59M | Buy |
+90,500
| New | +$2.59M | 0.04% | 109 |
|